Non-small cell lung cancer (NSCLC) Research Samples
28 Results
1 - 28 of 28 total samples.
Advanced Data View:
1 - 28 of 28 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 1 Detail | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Histological conclusion | Treatment status | TNM: | Stage | Grade | CT / MRI results | HIV-I/II, Hepatitis B, Hepatitis C Test Results |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BF19871322 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 60 Y | F | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 155 cm | Weight | 62 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN0M1 | IV | G2 | Formation of the upper lobe of the right lung, lymph nodes unchanged, metastases to the ribs | Negative | |||
| BF19871322-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 60 Y | F | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 155 cm | Weight | 62 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN0M1 | IV | G2 | Formation of the upper lobe of the right lung, lymph nodes unchanged, metastases to the ribs | Negative | |||
| BF19871323 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 57 Y | F | White | <-70C | 31-Oct-25 | Diagnosis | Lung Cancer | 15-Oct-2025 | Height | 162 cm | Weight | 74 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to the mediastinal lymph nodes and with metastases to the ribs | Negative | |||
| BF19871323-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 16.00 | $450.00 | 57 Y | F | White | <-70C | 31-Oct-25 | Diagnosis | Lung Cancer | 15-Oct-2025 | Height | 162 cm | Weight | 74 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N2M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to the mediastinal lymph nodes and with metastases to the ribs | Negative | |||
| BF19871324 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 64 Y | M | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 7-Oct-2025 | Height | 178 cm | Weight | 82 kg | $1,800.00 | Large cell carcinoma | Treatment-naive | T2N2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the pleura | Negative | |||
| BF19871324-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 64 Y | M | White | <-70C | 16-Oct-25 | Diagnosis | Lung Cancer | 7-Oct-2025 | Height | 178 cm | Weight | 82 kg | $450.00 | Large cell carcinoma | Treatment-naive | T2N2M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the pleura | Negative | |||
| BF19871325 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 78 Y | F | White | <-70C | 14-Oct-25 | Diagnosis | Lung Cancer | 8-Oct-2025 | Height | 161 cm | Weight | 71 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the liver | Negative | |||
| BF19871325-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 78 Y | F | White | <-70C | 14-Oct-25 | Diagnosis | Lung Cancer | 8-Oct-2025 | Height | 161 cm | Weight | 71 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to regional lymph nodes and distant metastases to the liver | Negative | |||
| BF19871326 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 74 Y | M | White | <-70C | 28-Oct-25 | Diagnosis | Lung Cancer | 24-Oct-2025 | Height | 172 cm | Weight | 84 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2aN2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and to the liver | Negative | |||
| BF19871326-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 74 Y | M | White | <-70C | 28-Oct-25 | Diagnosis | Lung Cancer | 24-Oct-2025 | Height | 172 cm | Weight | 84 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2aN2M1 | IV | G3 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and to the liver | Negative | |||
| BF19871327 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 65 Y | M | White | <-70C | 21-Oct-25 | Diagnosis | Lung Cancer | 16-Oct-2025 | Height | 173 cm | Weight | 81 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G1 | Formation of the upper lobe of the right lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871327-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 65 Y | M | White | <-70C | 21-Oct-25 | Diagnosis | Lung Cancer | 16-Oct-2025 | Height | 173 cm | Weight | 81 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G1 | Formation of the upper lobe of the right lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871328 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 17-Oct-25 | Diagnosis | Lung Cancer | 13-Oct-2025 | Height | 171 cm | Weight | 94 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to regional lymph nodes and ribs | Negative | |||
| BF19871328-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 68 Y | M | White | <-70C | 17-Oct-25 | Diagnosis | Lung Cancer | 13-Oct-2025 | Height | 171 cm | Weight | 94 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the middle lobe of the right lung with metastases to regional lymph nodes and ribs | Negative | |||
| BF19871329 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 74 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Lung Cancer | 9-Oct-2025 | Height | 174 cm | Weight | 83 kg | $1,800.00 | Squamous cell carcinoma | Treatment-naive | T1cN0M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the liver, lymph nodes unchanged | Negative | |||
| BF19871329-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 74 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Lung Cancer | 9-Oct-2025 | Height | 174 cm | Weight | 83 kg | $450.00 | Squamous cell carcinoma | Treatment-naive | T1cN0M1 | IV | G2 | Formation of the lower lobe of the right lung with metastases to the liver, lymph nodes unchanged | Negative | |||
| BF19871330 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 61 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 174 cm | Weight | 83 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the right lower lobe lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871330-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 61 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 10-Oct-2025 | Height | 174 cm | Weight | 83 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the right lower lobe lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871414 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 67 Y | F | White | <-70C | 21-Nov-25 | Diagnosis | Lung Cancer | 17-Nov-2025 | Height | 171 cm | Weight | 74 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871414-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 67 Y | F | White | <-70C | 21-Nov-25 | Diagnosis | Lung Cancer | 17-Nov-2025 | Height | 171 cm | Weight | 74 kg | $450.00 | Adenocarcinoma | Treatment-naive | T4N1M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871415 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 17-Nov-25 | Diagnosis | Lung Cancer | 30-Oct-2025 | Height | 181 cm | Weight | 79 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2bN1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871415-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 13.00 | $450.00 | 68 Y | M | White | <-70C | 17-Nov-25 | Diagnosis | Lung Cancer | 30-Oct-2025 | Height | 181 cm | Weight | 79 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2bN1M1 | IV | G3 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871416 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 63 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 18-Oct-2025 | Height | 164 cm | Weight | 72 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2bN2M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871416-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 63 Y | F | White | <-70C | 23-Oct-25 | Diagnosis | Lung Cancer | 18-Oct-2025 | Height | 164 cm | Weight | 72 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2bN2M1 | IV | G2 | Formation of the lower lobe of the left lung with metastases to regional lymph nodes and pleura | Negative | |||
| BF19871417 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 68 Y | M | White | <-70C | 13-Nov-25 | Diagnosis | Lung Cancer | 1-Nov-2025 | Height | 172 cm | Weight | 56 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871417-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 17.00 | $450.00 | 68 Y | M | White | <-70C | 13-Nov-25 | Diagnosis | Lung Cancer | 1-Nov-2025 | Height | 172 cm | Weight | 56 kg | $450.00 | Adenocarcinoma | Treatment-naive | T3N1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871418 | Non-small cell lung cancer (NSCLC) | Ukraine | Matched FFPE and Plasma (1mL) | 1.00 | 1.00 | $1,800.00 | 60 Y | F | White | <-70C | 03-Nov-25 | Diagnosis | Lung Cancer | 17-Oct-2025 | Height | 168 cm | Weight | 87 kg | $1,800.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative | |||
| BF19871418-P | Non-small cell lung cancer (NSCLC) | Ukraine | Plasma | 1.00 | 16.00 | $450.00 | 60 Y | F | White | <-70C | 03-Nov-25 | Diagnosis | Lung Cancer | 17-Oct-2025 | Height | 168 cm | Weight | 87 kg | $450.00 | Adenocarcinoma | Treatment-naive | T2aN1M1 | IV | G2 | Formation of the upper lobe of the right lung with metastases to the mediastinal lymph nodes and pleura | Negative |